Plicamycin is an antineoplastic antibiotic produced by Streptomyces plicatus. It is an RNA synthesis inhibitor. The manufacturer discontinued production in 2000.
Learn about Mithracin (Plicamycin) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Plicamycin is an antineoplastic antibiotic produced by Streptomyces plicatus. It has been used in the treatment of testicular cancer, Paget's disease of bone, and, ...
Plicamycin, which was formerly known as mithramycin, is an antibiotic that is used as an anticancer agent in the therapy of testicular cancer. Plicamycin causes ...
Physician reviewed plicamycin patient information - includes plicamycin description, dosage and directions.
Learn about the potential side effects of plicamycin. Includes common and rare side effects information for consumers and healthcare professionals.
Aug 5, 1997 ... Carcinoma, testicular (treatment)—Plicamycin is indicated for treatment of testicular carcinoma, although use has been replaced by that of more ...
Plicamycin is an anti-tumoral drug initially used for the treatment of testicular cancer that, by inhibiting RNA synthesis in osteoclasts, has a potent inhibitory effect ...
Plicamycin is an antibiotic isolated from Streptomyces plicatus. It binds to DNA and inhibits DNA, RNA, and protein synthesis in a manner similar to dactinomycin ...